Riboscience, Llc.

This study is testing whether an experimental drug called RBS2418, which aims to boost the immune system's ability to fight cancer, can help control advanced colorectal cancer. It will involve about 150 adults whose cancer has continued to progress despite trying all standard tre…

This study is testing whether adding a new drug called RBS2418 to an existing immunotherapy combination works better for people with advanced liver cancer that cannot be removed by surgery. About 220 participants will receive either the standard immunotherapy alone or the standar…

This is an early-stage study testing a new oral drug called RBS2418, both by itself and combined with an existing immunotherapy (pembrolizumab), in people with advanced cancers that have spread or returned. The main goals are to find safe doses and see how the body processes the …